Gene therapy increases survival for end-stage head and neck cancer
... at www.introgen.com .
Better Quality of Life
Patients treated with advexin
experienced far fewer harmful side effects such as pneumonia than those who... other tumor-suppressing genes systemically - through intravenous delivery. advexin
has to be injected straight into the tumor, but that's not workable for man...
Advexin in Medical Technology
Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - Introgen Therapeutics,
Inc. (NASDAQ:INGN) reported updated ADVEXIN(R) biomarker data over
the weekend in Los Angeles, California at the Annual Meeting of the
American Association for Cancer Research.
Abnormality of the p53 tumor suppressor is one of the...
Introgen's Advexin Demonstrates Clinical Benefit in Inherited
Case History Highlighted in AACR Cancer Journal
AUSTIN, Texas--(BUSINESS WIRE)--May 30, 2007--Introgen
Therapeutics, Inc. (NASDAQ:INGN) announced today the publication of
data describing the dramatic clinical benefit of its lead product
Advexin in a patient with a rare inherited form of cancer k...
Introgen Reports Updated Phase 2 Advexin Data Correlating Improved
Survival, Tumor Responses and Predictive p53 Biomarker
CHICAGO--(BUSINESS WIRE)--Jun 4, 2007 - Introgen Therapeutics, Inc.
(NASDAQ: INGN) and the Company's clinical collaborators today
reported updated Phase 2 data demonstrating a significant
correlation between abnormal p53, tumor responses and increased
survival following ADVEXIN(R) therapy in patien...
Advexin in Biological News
Abnormal overexpression of p53 is a predictive molecular biomarker
...otein were significantly more likely to respond to advexin
therapy than those whose tumor showed little p53 protein. advexin
is a gene based drug, injected directly into tumor...ormal p53 levels in cells are typically low.
is farthest along in federal Food and Drug Adminis...